EUVIMEDEUVIMED entdecken
Crossref

Emergence of an unconventional Enterobacter cloacae-derived Iturin A C-15 as a potential therapeutic agent against methicillin-resistant Staphylococcus aureus

Dipro Mukherjee, Samya Sen, Aniket Jana, Surojit Ghosh, Moumita Jash, Monika Singh, Satyajit Ghosh, Nabanita Mukherjee, Rajsekhar Roy, Tamal Dey, Shankar Manoharan, Surajit Ghosh und 1 weitere

Archives of Microbiology · 2025

DOI: 10.1007/s00203-024-04226-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Microbiology, 2025. Verfasst von Dipro Mukherjee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience and Bioengineering, Indian Institute of Technology, Jodhpur, Rajasthan, 342030, India. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Enterobacter cloacae, Peptides, Cyclic, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Science and Engineering Research Board, MHRD, India, iHUB Drishti Foundation, IIT Jodhpur.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance poses a significant global health threat by reducing the effectiveness of conventional antibiotics, particularly against pathogens like Methicillin-resistant Staphylococcus aureus (MRSA). This study investigates the antimicrobial potential of rhizospheric soil bacteria from Prosopis cineraria (Sangri) in the Thar Desert. Bacterial strains isolated from these samples were observed to produce secondary metabolites, notably, Iturin A C-15 cyclic lipopeptide (SS1-3-P) which was extracted from strain Enterobacter cloacae SS1-3 and was purified and characterized using reverse-phase HPLC, ESI-LC/MS, Nile-Red Assay, and FT-IR analysis. The presence of the Iturin A biosynthetic gene cluster was confirmed using gene-specific polymerase chain reaction and the biocompatibility of the purified product was assessed on HEK-293, WI38, and human RBCs. The potential of SS1-3-P to bind to and destroy MRSA membranes was validated using molecular dynamics simulation along with membranolysis and membrane depolarization assays. Antimicrobial assays like growth curve analysis, field emission scanning electron microscopy, and ROS generation confirmed the efficacy of SS1-3-P against clinical MRSA. Furthermore, the antibiofilm and anti-virulence properties of SS1-3-P were studied meticulously. Studies on NIH/3T3 cell lines and a murine excisional wound model showed significant wound-healing attributes of the lipopeptide. These results highlight the potential of desert ecosystems in developing effective antimicrobial therapies against recalcitrant nosocomial pathogens like MRSA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusEnterobacter cloacaePeptides, CyclicAnti-Bacterial AgentsHumansAnimalsMiceMicrobial Sensitivity TestsBiofilmsStaphylococcal InfectionsHEK293 CellsSoil MicrobiologyMultigene Family

Stichwörter der Autor:innen

AMRAntibioticsLipopeptidesMRSARhizosphereThar desert

Substanzen

Peptides, CyclicAnti-Bacterial Agentsiturin A

Autor:innen und Institutionen

  • Department of Bioscience and Bioengineering, Indian Institute of Technology, Jodhpur, Rajasthan, 342030, India.
  • iHUB Drishti Foundation, Indian Institute of Technology, Jodhpur, Rajasthan, India.
  • Smart Healthcare Department, Interdisciplinary Research Platform, Indian Institute of Technology, Jodhpur, Rajasthan, India.
  • Centre for Research and Development of Scientific Instruments (CRDSI), Indian Institute of Technology, Jodhpur, Rajasthan, 342030, India.
  • Department of Bioscience and Bioengineering, Indian Institute of Technology, Jodhpur, Rajasthan, 342030, India. sghosh@iitj.ac.in.
  • iHUB Drishti Foundation, Indian Institute of Technology, Jodhpur, Rajasthan, India. sghosh@iitj.ac.in.

Förderung

  • Science and Engineering Research Board
  • MHRD, India
  • iHUB Drishti Foundation, IIT Jodhpur
  • PMRF Program. Ministry of Education, Govt. of India
  • UGC, India

Zitieren

APA

Mukherjee, D., Sen, S., Jana, A., Ghosh, S., Jash, M., Singh, M., Ghosh, S., Mukherjee, N., Roy, R., Dey, T., Manoharan, S., Ghosh, S., & Sarkar, J. (2025). Emergence of an unconventional Enterobacter cloacae-derived Iturin A C-15 as a potential therapeutic agent against methicillin-resistant Staphylococcus aureus. Archives of Microbiology. https://doi.org/10.1007/s00203-024-04226-7

Vancouver

Mukherjee D, Sen S, Jana A, Ghosh S, Jash M, Singh M, et al. Emergence of an unconventional Enterobacter cloacae-derived Iturin A C-15 as a potential therapeutic agent against methicillin-resistant Staphylococcus aureus. Archives of Microbiology. 2025. doi:10.1007/s00203-024-04226-7

BibTeX
@article{Mukherjee2025,
  author = {Mukherjee, Dipro and Sen, Samya and Jana, Aniket and Ghosh, Surojit and Jash, Moumita and Singh, Monika and Ghosh, Satyajit and Mukherjee, Nabanita and Roy, Rajsekhar and Dey, Tamal and Manoharan, Shankar and Ghosh, Surajit and Sarkar, Jayita},
  title = {Emergence of an unconventional Enterobacter cloacae-derived Iturin A C-15 as a potential therapeutic agent against methicillin-resistant Staphylococcus aureus},
  journal = {Archives of Microbiology},
  year = {2025},
  doi = {10.1007/s00203-024-04226-7}
}
Kostenlos starten →